Articles related to Pediatric Endocrinology

Children labeled metabolically healthy at obesity treatment initiation reached an 18-fold higher type 2 diabetes incidence by age 30 than general population peers in a 42,911-patient Swedish cohort.

“Families and health care professionals now have the option to consider a once-weekly growth hormone as treatment with 313 injection free days per year for their children 2.5 years and older with ISS, NS, and born SGA,” said Dr Aristides Maniatis, Founder, Rocky Mountain Pediatric Endocrinology.

The societal influences, including parental weight stigma, affect how parents perceive their child’s weight and respond to health care recommendations.

“We try to deescalate pharmacotherapy as soon as we can in children. How’s this going to affect puberty? How’s it going to affect growth? We don’t have those long-term data.”

Analysis of more than 5 million adolescent insurance claims reveals that gender-affirming medication prescriptions remain exceptionally rare, with peak rates reaching only 140.16 per 100,000 at age 17 for AFAB adolescents.

Initial visit laboratory values, particularly HbA1C and 2-hour glucose, combined with BMI trajectory, offer more reliable predictive value for T2D progression than traditional fasting plasma glucose measurements.